News from arcturus therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 09, 2014, 06:15 ET
Arcturus Therapeutics Logo.

Arcturus Therapeutics Announces the Appointment of Michael R. Hodges, M.D. to the Scientific Advisory Board

 Arcturus Therapeutics Inc., a leading small interfering RNA (siRNA) and messenger RNA (mRNA) drug discovery and development company, today...

Dec 03, 2014, 06:15 ET
Arcturus Therapeutics Logo.

Arcturus Therapeutics to Present at the Genetic Rx Boston Biotech Conference

 Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced its participation on two panel...

Dec 01, 2014, 06:15 ET
Arcturus Therapeutics Logo.

Arcturus Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference

 Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced that Joseph E. Payne, President &...

Nov 10, 2014, 06:15 ET
Arcturus Therapeutics Logo

Arcturus Therapeutics Presents Preclinical Messenger RNA Data in Non-Human Primates at the 2nd International mRNA Health Conference

 Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced it will present a poster at the 2nd...

Nov 03, 2014, 06:05 ET
Arcturus, Arcturus Therapeutics

Arcturus Therapeutics Expands Operations in San Diego, CA

Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced the expansion of operations from the Johnson...

Oct 13, 2014, 06:15 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics to Present Gene Knockdown Data in Non-Human Primates, Showing up to 94% Reduction in Gene Expression with a Single Low Dose

Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced it will present a poster at the...

May 13, 2014, 06:15 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics Announces Allele-Specific Silencing Technology at IBC's 16th Annual TIDES Conference

 Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing rare diseases, today announced the nomination of its second pipeline...

May 06, 2014, 06:05 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics Appoints Robert Baltera and Stuart Collinson, Ph.D. to its Board of Directors

 Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing rare diseases, announced today the appointment of two new members to its...

Apr 07, 2014, 09:35 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics to Present at the 13th Annual Needham Healthcare Conference

Arcturus Therapeutics, Inc., a preclinical-stage RNA medicines company pursuing rare diseases, today announced its President & CEO, Joseph E....

Mar 27, 2014, 06:05 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics to Present at the BioCentury Future Leaders in the Biotech Industry Conference

 Arcturus Therapeutics, Inc., a next wave RNA medicines company pursuing orphan diseases, today announced that its president & CEO, Joseph...

Mar 10, 2014, 06:00 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics to Present at the BIO-Europe Spring Partnering Conference

 Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced that it has been selected to present at...

Feb 24, 2014, 12:20 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics to Present RNAi Data for Orphan Diseases Utilizing the LUNAR™ Technology Platform at BIOCOM's Global Life Science Partnering Conference

Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing rare diseases, today announced it will present at BIOCOM's Global Life...

Jan 30, 2014, 06:35 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics to Present at the Keystone Symposia Conference on RNA Silencing

 Arcturus Therapeutics, Inc. today announced it will present a poster at the Keystone Symposia Conference on RNA Silencing held January 31-...

Jan 13, 2014, 04:00 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program

Arcturus Therapeutics, Inc., an industry leader in RNA technologies, today announced its flagship program – an RNAi therapeutic targeting...

Jan 07, 2014, 06:35 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics, Inc. to Present at the Biotech Showcase 2014

 Arcturus Therapeutics, Inc., an industry leader in RNA technologies for the treatment of rare orphan diseases, today announced that Joseph...

Oct 28, 2013, 06:00 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer

 Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of rare orphan diseases, today announced the expansion...

Oct 21, 2013, 07:00 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics Raises $5 Million in Series A Funding to Maintain its Momentum in Nominating Lead Clinical Candidate in 2014

 Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of rare orphan diseases, today announced it has...

Aug 14, 2013, 07:00 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech

Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of disease, today announced it has acquired the patented...

Jun 03, 2013, 06:35 ET
Arcturus Therapeutics Logo.  (PRNewsFoto/Arcturus Therapeutics)

Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding

 Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of disease, today announced it has raised $1.3 million...